Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 174

    At least four pharma CEOs to testify at Senate drug pricing hearing

    At least four pharma CEOs to testify at Senate drug pricing hearing

    Medical Dialogues Bureau10 Feb 2019 9:00 AM IST
    Republican Senator Chuck Grassley, chairman of the Senate Finance Committee, and Democratic Senator Ron Wyden, ranking member of the committee on...
    Zydus Cadila gets USFDA nod for Carbamazepine extended release tablets

    Zydus Cadila gets USFDA nod for Carbamazepine extended release tablets

    Farhat Nasim9 Feb 2019 10:00 AM IST
    Carbamazepine is an anticonvulsant agent. It works by reducing excessive nerve signals in the brain and restoring the normal balance of nerve...
    Lupin gets 2 observations from USFDA for its Goa facility

    Lupin gets 2 observations from USFDA for its Goa facility

    Farhat Nasim9 Feb 2019 9:45 AM IST
    Mumbai: Soon after the inspection of its facility in Madhya Pradesh, the Mumbai-based, Lupin Ltd recently got a couple of key observations for it's...
    Aurobindo Pharma Q3 profit rises 19.69 percent to Rs 712 crore on robust sales

    Aurobindo Pharma Q3 profit rises 19.69 percent to Rs 712 crore on robust sales

    Garima9 Feb 2019 9:30 AM IST
    Commenting on the results, Aurobindo Pharma MD N Govindarajan said: "We have delivered robust revenue growth of 22 per cent, driven by strong growth...
    Pharmacy stocks run low; Diabetes, BP patients leave empty handed

    Pharmacy stocks run low; Diabetes, BP patients leave empty handed

    Farhat Nasim9 Feb 2019 9:00 AM IST
    * Pharmacists say medicine warehouses don't have drugs * Government forex curbs affect prices firms can charge* Health ministry says will raise prices...
    Narayana Hrudayalaya former MD, CEO Ashutosh Raghuvanshi joins Fortis Healthcare as new CEO

    Narayana Hrudayalaya former MD, CEO Ashutosh Raghuvanshi joins Fortis Healthcare as new CEO

    Farhat Nasim8 Feb 2019 11:59 AM IST
    New Delhi: Ex-Managing Director(MD) and Group CEO of Narayana Hrudayalaya, Ashutosh Raghuvanshi has been appointed as the new Chief Executive...
    Glenmark gets tentative USFDA nod to breast cancer injection Fulvestrant

    Glenmark gets tentative USFDA nod to breast cancer injection Fulvestrant

    Farhat Nasim8 Feb 2019 11:40 AM IST
    Fulvestrant injection is a generic version of AstraZeneca Pharmaceuticals LP's Faslodex injection in the same strength, it added. The Faslodex...
    Cadila Healthcare Q3 profit falls 6 percent to Rs 511 crore on rising expenses

    Cadila Healthcare Q3 profit falls 6 percent to Rs 511 crore on rising expenses

    Garima8 Feb 2019 11:35 AM IST
    Cadila Healthcare had posted a net profit of Rs 543.3 crore in the corresponding period of the previous fiscal, the drug firm said in a filing to...
    Health Horizons launches its range of Hemp Soaps

    Health Horizons launches its range of Hemp Soaps

    Medical Dialogues Bureau8 Feb 2019 9:00 AM IST
    Health Horizons are manufacturers and distributors of consumable and skincare products derived from the miracle plant - Hemp.NOIDA: Health Horizons,...
    Lupin posts Q3 loss of Rs 152 crore on litigation over Perindopril

    Lupin posts Q3 loss of Rs 152 crore on litigation over Perindopril

    Farhat Nasim7 Feb 2019 2:23 PM IST
    Lupin had a net loss of 1.52 billion rupees compared to a profit of 2.22 billion rupees in the same quarter last year, the company said.Mumbai: A...
    Strides Pharma gets EIR for Bangalore facility

    Strides Pharma gets EIR for Bangalore facility

    Farhat Nasim7 Feb 2019 11:32 AM IST
    "The company's formulations facility (KRSG Gardens) in Bangalore which was inspected by the US Food and Drug Administration (USFDA) in August 2018 and...
    Sanofi gets FDA nod to blood disorder drug Cablivi

    Sanofi gets FDA nod to blood disorder drug Cablivi

    Farhat Nasim7 Feb 2019 9:30 AM IST
    Cablivi was originally developed by Ablynx, a Belgium biotech firm that Sanofi acquired in January last year for 3.9 billion euros ($4.53 billion)...
    PrevNext

    Popular Stories

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok